Maker of Wegovy and Ozempic has 45,000 patients in clinical trials as it seeks to stave off threats from Eli Lilly and Roche
Patients in Manchester will take part in first study using ‘wonder material’ that was discovered in the city
For years, the process for developing and testing new drugs has focused disproportionately on male bodies — to the detriment of female patients
Reducing 14 ‘modifiable’ risks can prevent or delay cognitive disorder, report says
The illness causes more deaths than strokes but a new time-saving technology may be able to help
Nice blames cost for not recommending Enhertu, which has helped patients in clinical trials live longer
Extreme shortages of actinium are holding up the promising field of radiopharmaceuticals
Eisai and Biogen face uphill battle to win EU approval for Leqembi after committee’s ruling
Chan Siun-kuen left rural China in the slipstream of the revolution for a rapidly urbanising Hong Kong. His herb garden restores a connection to forgotten traditions and the healing power of plants
GSK’s Shingrix is latest drug to show potential for targeting previously untreatable brain disorders
Amber alert triggered as blood stocks fall to ‘unprecedentedly low levels’
Health organisation says the risk of transmission is high because of ‘the very dire situation with water sanitation’
Shares are down 70% for the world’s largest maker of insulin pen needles and syringes since it was spun off
Swiss drugmaker says it will only sell medication privately if health systems cannot pay
Report finds focus on influenza, preparations for no-deal Brexit and ‘groupthink’ strategy hampered response to virus
Treatment based on science that helps axolotl salamanders restore lost limbs is now in human trials
EU court rules that European Commission unlawfully withheld information about procurement
There is concern that medications used widely for weight loss have not been tested for use by pregnant women
Use of Car-T for lupus could drive surge in demand for a treatment that was first approved for blood cancers
New compound increases strength of antidote for fentanyl and other lethal drugs
New agreement hands UK drugmaker control of developing jabs and provides cash injection for German group
Pfizer and BioNTech infringed pharmaceutical group’s mRNA patent, High Court in London rules
Federal health officials step up efforts to boost jab stockpiles in response to widening outbreak
Neurotech advance gives patients in MIT study walking speed and control closer to people who had not lost limbs
Information about patients remains ‘liquid gold’ when it comes to enriching medical research
